Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology (Q44916704)

7 December 2017

Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology (English)

1 reference

7 December 2017

0 references

chronic heart failure

1 reference

14

Klaus K Witte

1 reference

7 December 2017

10

Ramzi Ajjan

1 reference

7 December 2017

8

Christopher P Gale

0 references

Mark Kearney

15

object named as

Mark T Kearney

1 reference

7 December 2017

12

Stephen B Wheatcroft

1 reference

7 December 2017

1

Richard M Cubbon

1 reference

7 December 2017

11

Lorraine Kearney

1 reference

7 December 2017

13

Robert J Sapsford

1 reference

7 December 2017

9

Phillip D Batin

1 reference

7 December 2017

6

Peysh A Patel

1 reference

7 December 2017

Brook Adams

2

1 reference

7 December 2017

Adil Rajwani

3

1 reference

7 December 2017

Adil Rajwani

4

1 reference

7 December 2017

Ben N Mercer

5

1 reference

7 December 2017

Guy Gherardi

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

24 January 2013

1 reference

Diabetes and Vascular Disease Research

7 December 2017

1 reference

7 December 2017

10

1 reference

7 December 2017

330-336

1 reference

7 December 2017

4

1 reference

Diabetes in heart failure: prevalence and impact on outcome in the population

7 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

Diabetes, left ventricular systolic dysfunction, and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112471064

21 January 2018

Identifiers

DOI

10.1177/1479164112471064

1 reference

7 December 2017

1 reference